While high VISTA expression is generally associated with poor prognosis in patients [125], it also has been found to correlate with improved survival in early-stage endometrial cancer and esophageal adenocarcinoma (EAC) patients [15,126]. This evidence concerns the gene VSIR and esophageal adenocarcinoma.